Tutorials
Gilead Sciences Inc logo

Gilead Sciences Inc

$ 61.09 -0.82 (-1.32%) 10:08 PM EST
On watch
P/E:
18.63
P/B:
3.79
Market Cap:
$ 76.63B
Enterprise V:
$ 97.51B
Volume:
6.01M
Avg Vol (2M):
6.86M
Also Trade In:
Volume:
6.01M
Market Cap $:
76.63B
PE Ratio:
18.63
Avg Vol (2-Month):
6.86M
Enterprise Value $:
97.51B
PB Ratio:
3.79
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Gilead Sciences Inc
NAICS : 325412 SIC : 2834
333 Lakeside Drive, Foster, CA, USA, 94404
Description
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Financials (Next Earnings Date:2022-10-28 Est.)

GILD's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:GILD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 27,515
EPS (TTM) ($) 3.28
Beta 0.01
Volatility % 22.5
14-Day RSI 48.89
14-Day ATR ($) 1.330331
20-Day SMA ($) 61.254
12-1 Month Momentum % -10.04
52-Week Range ($) 57.165 - 74.12
Shares Outstanding (Mil) 1,254.31

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Gilead Sciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More